Navigation Links
Novavax Announces Top Line Results of Phase IIa Clinical Trial for Its Seasonal Influenza VLP (Trivalent) Vaccine Candidate
Date:12/11/2008

Favorable immunogenicity results for seasonal vaccine program follows positive results from its pandemic influenza vaccine Phase IIa trial in July 2008; plans to initiate a study of the seasonal vaccine in the elderly in 2009

ROCKVILLE, Md., Dec. 11 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) announced today favorable results from a Phase IIa human clinical trial of its seasonal influenza VLP (trivalent) vaccine candidate. The vaccine, which does not include an adjuvant, induced robust hemagglutination inhibition (HAI) responses, which have been shown to correlate with protection against seasonal influenza disease.

The Phase IIa randomized, placebo-controlled clinical trial evaluated the safety and immunogenicity of different doses of Novavax's seasonal influenza VLP vaccine. Specifically, the vaccine was studied in approximately 300 healthy adults between the ages of 18 to 49 years, who received a single injection of either a placebo or an influenza vaccine at doses of 5 mcg, 15 mcg or 30 mcg per strain.

The adverse events that were reported from the trial are similar in type to those reported for other approved influenza vaccines. Adverse events such as fever, chills, joint pain, muscle aches, headaches, and fatigue were reported at a higher frequency among vaccine as compared with placebo recipients. No serious adverse events have been reported to date. Subjects in the study continue to be monitored for safety through 6 months after vaccination.

The vaccine was immunogenic, inducing HAI responses against the vaccine strains and drifted strains. For subjects in the 15 mcg or 30 mcg vaccination groups, seroprotection rates (i.e., percentage of subjects with HAI titers greater than or equal to 40) for the vaccine strains ranged from 95 to 97% for H3N2, 83 to
'/>"/>

SOURCE Novavax, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Novavax CEO to Present at ACUMENBioFins 9th Annual Healthcare Conference
2. Novavax Reports Third Quarter 2007 Financial Results and Progress with Vaccine Development Programs
3. GE Healthcare and Novavax Establish Collaboration To Develop and Market Pandemic Influenza Solution
4. Novavax Announces Preclinical Results for Seasonal Influenza Vaccine Program
5. Novavax Announces Favorable Interim Results from Human Clinical Trial for Its Pandemic Influenza Vaccine Program
6. Novavax Reports Fourth Quarter and 2007 Year-End Financial Results
7. Novavax Reports Positive Results from Preclinical Studies of its VLP-based Trivalent Seasonal Influenza Vaccine Candidate
8. Novavax Completes Enrollment in Phase I/IIa Pandemic Influenza Vaccine Clinical Trial
9. Novavax Announces Proprietary Method to Create SARS Vaccine and Renewal of NIH Funding for SARS Vaccine Development
10. Novavax to Present Phase I/IIa Trial Data Results in an Investor Conference Call on August 26, 2008
11. Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... -- Research and Markets( http://www.researchandmarkets.com/research/bkw8kk/pharmaceutical ) ... Market in North America 2015-2019" report to their ... North America to grow at a ... International regulations regarding safe drug delivery are enforced ... fuels adoption of sustainable packaging. Various raw materials such ...
(Date:7/6/2015)... Hologic, Inc. (NASDAQ: HOLX ) announced ... results for the third quarter of fiscal 2015 on ... conjunction with the release, management will host a conference ... Interested participants may listen to the call by ... ) or 719-325-4804 (for international callers) and referencing access ...
(Date:7/6/2015)... 29, 2015 Research and ... "Pharmaceutical Grade Sodium Chloride Market by Applications, by ... report to their offering. The pharmaceutical grade ... of 6.9% between 2014 and 2019 in terms of ... KT by 2019. The report on Pharmaceutical ...
Breaking Medicine Technology:North American Pharmaceutical Packaging Market 2015-2019 with Amcor, Bemis Healthcare Packaging, MeadWestvaco, Owens-Illinois & West Pharmaceutical Services Dominating 2North American Pharmaceutical Packaging Market 2015-2019 with Amcor, Bemis Healthcare Packaging, MeadWestvaco, Owens-Illinois & West Pharmaceutical Services Dominating 3Hologic to Announce Financial Results for the Third Quarter of Fiscal 2015 on Wednesday, July 29, 2015 2Global Pharmaceutical Grade Sodium Chloride Market Report 2015 2Global Pharmaceutical Grade Sodium Chloride Market Report 2015 3
... DIEGO and INDIANAPOLIS, June 24, 2011 Eli ... results from an analysis designed to evaluate the cost-effectiveness of ... long-acting insulin analog (LAIA). The analysis indicated ... experience frequent hypoglycemia, insulin lispro premixed insulin analogs are likely ...
... SAN and NYSE: SNY ) announced today ... intensified insulin regimens added to oral therapy for uncontrolled ... including Lantus® (insulin glargine [rDNA origin] injection) and Apidra® ... compared to premixed insulin with less hypoglycemia and improvement ...
Cached Medicine Technology:Analysis Compares Cost-Effectiveness of Premixed Insulin Analogs to Long-Acting Insulin Analogs in the Long-Term Treatment of Type 2 Diabetes in the U.S. 2Analysis Compares Cost-Effectiveness of Premixed Insulin Analogs to Long-Acting Insulin Analogs in the Long-Term Treatment of Type 2 Diabetes in the U.S. 3Analysis Compares Cost-Effectiveness of Premixed Insulin Analogs to Long-Acting Insulin Analogs in the Long-Term Treatment of Type 2 Diabetes in the U.S. 4Analysis Compares Cost-Effectiveness of Premixed Insulin Analogs to Long-Acting Insulin Analogs in the Long-Term Treatment of Type 2 Diabetes in the U.S. 5Analysis Compares Cost-Effectiveness of Premixed Insulin Analogs to Long-Acting Insulin Analogs in the Long-Term Treatment of Type 2 Diabetes in the U.S. 6Analysis Compares Cost-Effectiveness of Premixed Insulin Analogs to Long-Acting Insulin Analogs in the Long-Term Treatment of Type 2 Diabetes in the U.S. 7Sanofi Announces Positive Results from the "All to Target" Study Evaluating Two Lantus® and Apidra® Regimens Versus Premixed Regimen 2Sanofi Announces Positive Results from the "All to Target" Study Evaluating Two Lantus® and Apidra® Regimens Versus Premixed Regimen 3Sanofi Announces Positive Results from the "All to Target" Study Evaluating Two Lantus® and Apidra® Regimens Versus Premixed Regimen 4Sanofi Announces Positive Results from the "All to Target" Study Evaluating Two Lantus® and Apidra® Regimens Versus Premixed Regimen 5Sanofi Announces Positive Results from the "All to Target" Study Evaluating Two Lantus® and Apidra® Regimens Versus Premixed Regimen 6
(Date:7/6/2015)... , ... July 06, 2015 , ... ... that eliminates 100% of all acids, chemicals and impurities; it also properly mineralizes ... water because it contains harmful contaminants.  These harmful contaminants are a byproduct of ...
(Date:7/6/2015)... ... July 06, 2015 , ... Shortly after opening her second practice in ... of doctors working on a lien basis. Dr. Lim had previously worked with ... of two Cambodian refugees, Dr. Lim suffered with back pain herself throughout high school. ...
(Date:7/6/2015)... ... July 06, 2015 , ... Olive Fertility Centre is proud to announce that ... Award on behalf of the department of Family Practice. , “This award is a ... practicing in. The technology is changing so rapidly and we are also developing new ...
(Date:7/6/2015)... CA (PRWEB) , ... July 06, 2015 , ... Seedstock ... deliver the keynote address at the 4th Annual Seedstock Sustainable Agriculture Conference – “Innovation ... year’s conference , held at the University of California-San Diego, will explore solutions ...
(Date:7/6/2015)... , ... July 06, 2015 , ... With a new ... up with Livonia Save Our Youth and announced a new charity campaign to raise ... regards to alcohol and drug abuse. Livonia Save Our Youth is a coalition created ...
Breaking Medicine News(10 mins):Health News:Pristine Water Filters.com Offers The 1st Water Revival System That Re-Mineralizes Drinking Water and Eliminates All Impurities and Chemicals 2Health News:Respected Chiropractor Opens Office in Signal Hill/Cambodia Town and Joins Doctors on Liens 2Health News:Olive Fertility Centre Physician Honoured for Teaching 2Health News:Seedstock Names Go Green Agriculture Founder and CEO as 2015 Sustainable Agriculture Conference Keynote Speaker 2Health News:Seedstock Names Go Green Agriculture Founder and CEO as 2015 Sustainable Agriculture Conference Keynote Speaker 3Health News:Seedstock Names Go Green Agriculture Founder and CEO as 2015 Sustainable Agriculture Conference Keynote Speaker 4Health News:Bowker Insurance Group and Nonprofit Livonia Save Our Youth Initiate New Charity Campaign in Livonia, MI to Provide for The Health and Safety of The Communities’ Youth 2Health News:Bowker Insurance Group and Nonprofit Livonia Save Our Youth Initiate New Charity Campaign in Livonia, MI to Provide for The Health and Safety of The Communities’ Youth 3
... (HealthDay News) -- American consumers don,t pay as much ... a new study finds. Researchers asked 203 people ... displayed on a computer screen. The information included the ... ingredients, and a description of the product that included ...
... in the United States who have the cornea-damaging disease keratoconus ... that is already proving effective in Europe and other parts ... in almost 70 percent of patients treated for keratoconus in ... is in clinical trials in the United States and is ...
... New research from the Heart and Stroke Foundation and ... people with spinal cord injury (SCI) have a higher risk ... nervous system is a key predictor of cardiovascular risk, researcher ... the Heart and Stroke Foundation and the Canadian Cardiovascular Society. ...
... , SATURDAY, Oct. 22 (HealthDay News) -- While there are ... an expert says. "They can enjoy Halloween and enjoy ... Dr. Kenneth McCormick, a pediatric endocrinologist and senior scientist at ... in a university news release. "We give parents and ...
... young adulthood and diet appeared to be associated with ... at the 10th AACR International Conference on Frontiers in ... causes of non-Hodgkin lymphoma (NHL) are poorly understood, and ... to prevent or lower the risk for this disease," ...
... Women hospital staff working night shifts may be compromising ... health of patients, Dr. Joan Tranmer told the Canadian ... Foundation and the Canadian Cardiovascular Society. Dr. Tranmer,s ... factors for heart disease in female hospital employees who ...
Cached Medicine News:Health News:Do You Really Read Nutrition Labels? 2Health News:Vitamin B-based treatment for corneal disease may offer some patients a permanent solution 2Health News:Spinal cord injuries associated with increased risk of heart disease 2Health News:Spinal cord injuries associated with increased risk of heart disease 3Health News:Healthy Halloween Advice for Children With Diabetes 2Health News:Body weight, diet may be risk factors for non-Hodgkin lymphoma 2Health News:Female shift workers may be at higher risk of heart disease 2Health News:Female shift workers may be at higher risk of heart disease 3
... determination of Ang II is ... the pharmacological effect and efficiency ... angiotensin converting enzyme inhibitors (ACE ... antagonists as well as for ...
... antigen test is a visual ... presumptive qualitative detection of Respitory ... specimens in neonatal and pediatric ... test has a built-in procedural ...
Rapid Immunoassay for the detection of Respiratory Syncytial Virus....
... BD Directigen EZ RSV Test utilizes a new, ... one device for rapid RSV detection. The testing ... method whereby dried reagents have already been applied ... a two-step process, with clear-cut results shown by ...
Medicine Products: